WCPO: Next battle over access to abortion will focus on pills
UC law expert in race, gender & social justice discusses the Supreme Court and abortion access
All eyes are on the U.S. Supreme Court which is expected to revisit the scope of Roe v. Wade ruling in 1973, which granted a constitutional right for pregnant women in the United Stated States to have an abortion without undue government intervention. For women seeking abortions, the use of pills sent via mail to induce abortions may grow in importance if the Supreme Court approves its leaked draft opinion that overturns the Roe v. Wade decision and allows individual states to curtail or ban abortion. Jenn Dye, PhD, Theodore M. Berry Director of the Nathaniel R. Jones Center for Race, Gender, and Social Justice, in the UC College of Law, was among the experts speaking about the topic with WCPO journalist Mariel Carbone.
Listen to the WCPO segment online.
Learn more about the work of Jenn Dye, PhD, online.
Featured photo of pills and contraceptive devices courtesy of Unsplash.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.